Effectiveness of continuous allergenic food intake for acute food protein–induced enterocolitis syndrome
Journal of Allergy and Clinical Immunology: Global · 2024-05 · 3 (2) · 100232
DOI: 10.1016/j.jacig.2024.100232 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Allergy and Clinical Immunology: Global, 2024-05. Verfasst von Masaaki Hamada und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Yao Municipal Hospital, Osaka, Japan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Continuous intake of allergenic food is a safe and efficient treatment strategy for patients with a prolonged course of acute food protein-induced enterocolitis syndrome. The initial dose, dose escalation rate, and starting age for continuous allergenic food intake need further clarification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Yao Municipal Hospital, Osaka, Japan.
- Department of Legal Medicine, Nara Medical University School of Medicine, Kashihara, Japan.
Zitieren
APA
Hamada, M., Sakurai, Y., & Tanaka, I. (2024). Effectiveness of continuous allergenic food intake for acute food protein–induced enterocolitis syndrome. Journal of Allergy and Clinical Immunology: Global, 3(2), 100232. https://doi.org/10.1016/j.jacig.2024.100232
Vancouver
Hamada M, Sakurai Y, Tanaka I. Effectiveness of continuous allergenic food intake for acute food protein–induced enterocolitis syndrome. Journal of Allergy and Clinical Immunology: Global. 2024;3(2):100232. doi:10.1016/j.jacig.2024.100232
BibTeX
@article{Hamada2024,
author = {Hamada, Masaaki and Sakurai, Yoshihiko and Tanaka, Ichiro},
title = {Effectiveness of continuous allergenic food intake for acute food protein–induced enterocolitis syndrome},
journal = {Journal of Allergy and Clinical Immunology: Global},
year = {2024},
volume = {3},
number = {2},
pages = {100232},
doi = {10.1016/j.jacig.2024.100232}
}
EUVIMED